28 YEARS LATER Cast and Crew on Returning to a Rage-Filled World
It hasn't been a full 28 years since 28 Days Later, but it's getting very close. We almost can't fully process just how influential and innovative the original movie was in 2002. Not only did it provide a jumpstart to the zombie (or zombie-like creature) genre, it gave the world fast-running hordes. Technologically, the movie's use of handheld digital cameras proved equally as cutting edge, even if it looks quite rough by today's standards. On returning to the story with 28 Years Later, director Danny Boyle and writer Alex Garland wanted to do more than just rehash. They wanted to explore the premise through a 2025 lens.
Nerdist spoke to Boyle and Garland, as well as actors Jodie Comer and Aaron Taylor-Johnson, about 28 Years Later and blending family drama with rage-infected scares.
'I think we wanted to do something different,' Boyle told us. 'You have to be sensible. You are obviously basing it on the original movie. There is a debt that you hold and that you have to acknowledge, but we wanted to make it as minimal as possible. So much so that although we had Cillian [Murphy]'s agreement to be involved and he's part of [the later films] and that freed us up to try and make an original film with, like I said, a certain acknowledgement of the debt.'
The movie's story, while still about people surviving a plague-destroyed landscape, is very different from the first movie. Great Britain has been completely quarantined from the rest of the world. Mainland Europe has managed to eradicate the rage virus, but no British person is allowed to leave. This means the people who live there have had to manage in a new agrarian society and fortify their communities. At the same time, the infected have had almost 30 years to evolve.
'We want to move them on through the 28 years time passage to see how they've evolved,' Boyle continued. 'To see how the infection, the virus has moved to survive itself. Just like the survivors have established a world that they built from zero about how they can survive without electricity, without technology. So the instinct was to be as original as possible, as much as possible throughout.'
'To me it's just sort of what life is like,' Garland said of the rest of the movie's world ignoring the plight of Britain. 'While we are talking right now, there are some incredibly serious conflicts happening at this exact moment and here we are talking about a movie release. The world does have a really eerie, slightly creepy ability to compartmentalize and does it very naturally.'
'What the film is doing,' he continued, 'is just putting Britain in the state of one of those sort of acknowledged but also concurrently forgotten. And yes, the world carries on, has Amazon drivers, has people augmenting their face with collagen or whatever it is they do, and just carrying on as per normal.'
The reality, the normal, is a major part of the lives of the characters in the movie. The relative safety of the small, offshore community allows for the family drama element to come to the forefront. At the center, we find Jamie (Taylor-Johnson) prepared to take son Spike (Williams) on his first 'hunt,' while wife/mother Isla (Comer) remains largely bedridden with an unknown illness.
'I think the beauty of that is Alex Garland wrote a story where these characters are so rich,' Taylor-Johnson explained. 'On the page, it's a very intimate family drama. So I think you kind of just play into the reality of that and the groundedness. But it's weird. You don't almost play into the horror aspect. You're sort playing into the truth.'
'We also had a two week rehearsal period before we started shooting,' Comer added. 'Then our first week, at least, my first week on set, was in the house [together]. We went from the rehearsal room where Danny had set up the bedroom, we had all the props, and then we went straight into that set, which was amazing.'
She continued, 'Danny would often play out multiple scenes in order to get momentum and to really create an energy on set. It worked, and I think the rehearsals helped all of us. It was great for us to meet each other, get familiar, and kind of create some history between us.'
The society of the island also feels fully realized and the people have gone back to an older, more traditional existence. Boyle says this, too, reflects our own times. '[It's been] happening around the world over the last maybe 10 years,' the director continued. 'This tendency to look back to the glorious past and to imagine that one might be able to live there again. Faced with the lack of electricity and the lack of technology, they have almost naturally regressed back to us almost 1950s-type existence.'
Part of that, he continued, was reverting to traditional gender roles. 'The boys and the girls have been separated and gender become identified again as your key roles are to do with your gender. So the boys are trained to fight and to kill and the girls to prepare the food at home. And it was just that looking backwards was really, I think a key part of the journey of the world building of them.'
But Spike, as our lead character, doesn't fully conform. 'The boy has a decision to make by the end of the film,' Boyle explained. 'Will he return to his father as his father's whole role model suggests and steps into the footsteps of his father and life progresses in that way. Or will he try and find something else? He'll, of course, find out what he's going to step into is very, very dangerous indeed.'
You can see the danger for yourself when 28 Years Later hits cinemas on Friday, June 20.
Kyle Anderson is the Senior Editor for Nerdist. He hosts the weekly pop culture deep-dive podcast Laser Focus. You can find his film and TV reviews here. Follow him on Letterboxd.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
27 minutes ago
- Yahoo
Danny Boyle and Jodie Comer talk Covid, horror and making 28 Years Later
When 28 Days Later hit screens in 2002, it unleashed a new tangible sense of everyday terror, as Cillian Murphy stumbled around London's chillingly deserted streets and landmarks, emptied by a zombie virus outbreak. In March 2020, the dystopian nightmare became reality when the Covid pandemic transformed the capital into a ghost town. Whereas Murphy's character saw Oxford Street awash with "missing" posters, today a memorial wall stands opposite Parliament to commemorate the 200,000 UK dead. It is in this ever-changed climate that original director Danny Boyle and writer Alex Garland have returned to their virus-filled world with 28 Years Later. Speaking to BBC News, Boyle says that for audiences, going through a sudden life-threatening transformation - even without zombies - has intensified the terror, because "what we used to think only belonged in movies" now "feels more possible". But it is the way we adapted to Covid, and learned to live within the confines of an unstable, vulnerable reality, that he says is central to the new film. In this latest chapter, the "infected" - victims of the lab-leaked Rage Virus, last shown reaching Europe at the end of Juan Carlos Fresnadillo's 2007 sequel 28 Weeks Later - have been pushed back and re-confined to British shores. As the rest of the world heals, Britain's remaining survivors have been left to fend for themselves. Among them is 12-year-old Spike (Alfie Williams), who lives with his father Jamie (Aaron Taylor-Johnson) and housebound mother Isla (Jodie Comer) on Holy Island, off England's north-east coast. He's only ever known a feudal life in this 150-strong sanctuary, connected to the quarantined mainland by a single, heavily defended causeway that's only accessible at low tide. Now the gap between adults and children isn't just generational - it's divided between those who remember life pre-outbreak and those born post-virus. The needs-must attitude sees Jamie take Spike on a rite of passage hunt on the mainland for his 12th birthday. Just as humanity appears to have adapted, so too have the infected - who are now more evolved. Some crawl, while others have become Alphas, leading fast-running packs. The Rage Virus, it seems, never quietened - it grew. "Gradually, you start to take more risks - you start to explore just how far you can go and still stay safe," Boyle says of the film's Covid parallels. "That's unimaginable 28 days after the infection. But 28 years after the infection, those are the kinds of risks they take." Boyle says the decision to have a young lead character was intentional, not only because "horror loves innocence", but also to explore the truths adults choose to tell children - and hide from them - in order to keep going. The emotional tension is something Comer can relate to, on and off screen. "I've felt it with my own parents," she says, speaking to me beside Boyle. "When they've tried to protect me from something, thinking it was better not to worry me. But there have been moments where I've thought, I really wish you'd shared that with me because I might have done something differently... or had more time with someone. But ultimately, it's always coming from a place of love." It's a trait shared by her character, Isla. As mother to Spike, Isla is clearly sick but still desperately trying to care for him, even while slipping in and out of lucidity - apparently ravaged with confusion from decades under siege. But the reality is more complex. Comer is no stranger to crisis storylines. She played the mother of a newborn facing an apocalyptic flood in The End We Start From, and a care home nurse in Covid drama Help! But 28 Years Later marks her first portrayal of someone so deep into post-apocalyptic living. It's also her first time facing zombies. So what's it like being chased by the infected? "Thrilling," she replies. The scenes were grounded in the film's gritty realism. No CGI or green screen was used, with the "infected" actors sometimes spending hours in the make-up chair. "These performers, they aren't taking the pace off," she says with a laugh. "There are moments that feel incredibly heightened - you're out of breath, facing elements of hysteria - but it's brilliant." Isla goes from debilitation to windows of composure: helping to deliver a baby or seeing off one of the infected with muscle memory precision that shows a glimpse of her past. Comer admits that navigating the emotional "ebbs and flows" of Isla's awareness was the most difficult aspect of the role. Boyle's films - from Trainspotting to the Oscar-winning Slumdog Millionaire - have always explored social truths. For him, the subtlety of Isla's relationship with Spike is important, as she helps the boy understand there's more to life than what the director calls "aggressive manhood". "There are different ways of progressing," Boyle says. "And he learns that, I think. He's able to step out into the world more fully armed than what just bows and arrows gives him." Comer adds: "There's an essence of hope through him and his curiosity." Boyle sees this film as the first of a trilogy, with Spike potentially appearing in all three. The second film, already shot by director Nia DaCosta, with Garland again writing, is due for release next year. Boyle plans to return for the third film, if it's green-lit. When I ask Boyle why, as a director of many genres, he's returning to horror so ambitiously, especially with the zombie-ridden The Last of Us TV adaptation dominating the zeitgeist, he suggests he was spurred on by an urgent political undercurrent. Alongside Spike's lessons in humanity, Boyle highlights a stagnant culture on the island, which is "not progressive, standing still... looking back to the halcyon days of England". The director describes the island's feudal way of life as deceptively safe but ultimately regressive – something Spike comes to realise. For Boyle, it reflects today's political climate and its dangers. "I think putting that in a horror film is a good thing," he says. "Because I think it will lead us to horror - and we know it will. We can see it beginning to happen even around us. Horror is a great genre for that, and it's one of the reasons it remains so popular." With so much real conflict around the globe, horror films feed off the sense that "huge change could be just around the corner" in the world as we know it, Boyle says. In the original 28 Days Later, the Rage Virus was developed by forcing chimps to watch graphic video footage. I ask Boyle whether he sees a parallel in the real-life rise of social media, with its personalised algorithm that's designed to reward polarising, rage-inducing content. "We're encouraged to communicate through these things," he replies, swiftly holding up his phone. "They're incredibly powerful – and easily manipulable. But they make us go through [the screen] to talk to each other." By contrast, he says there's "something intangible but amazing about cinema" and other collective human experiences. What matters is the authentic connection from cinema - sharing something "which is not about this", he says, gesturing to his phone. "It's very fragile, but it's very important, and we must hang on to it, as much as can." For Boyle, then, 28 Years Later is about audiences facing terror as one as much as the horror itself - real or imagined. Two decades on, we know all too well how they can blur.
Yahoo
30 minutes ago
- Yahoo
Brenus Pharma and InSphero Have Developed 3D Tumor Spheroids Mimicking in vivo Human Colorectal Cancer Conditions and Confirming STC-1010's Efficacy
Presented at EACR 2025, promising results show the impact of Brenus Pharma and InSphero's collaboration in advancing translational immunotherapy through scalable 3D tumor models. LISBON, Portugal, June 19, 2025--(BUSINESS WIRE)--Brenus Pharma, a French biotech developing next-generation first-in-class immunotherapies, and InSphero, a Swiss leader in 3D cell-based assay technologies, presented promising data at the European Association for Cancer Research 2025 annual congress. These data confirm the use of 3D tumor spheroids for potency testing of STC-1010, Brenus' lead candidate for colorectal cancer. Funded through the EUROSTARS program, the collaboration led to vitrified 3D colorectal cancer spheroids using tumor cell lines co-cultured with fibroblasts. The vitrification method preserves morphology, stromal integrity, and viability after thawing, enabling realistic evaluation of STC-1010's therapeutic potential under conditions mimicking in vivo human tumors. Previous studies showed that STC-1010 antigens were effectively processed by monocyte-derived dendritic cells (mMo-DCs), activating CD8+ T cells. These T cells induced apoptosis in both 2D and 3D colorectal cancer models and released anti-tumor cytokines (IFNγ and Granzyme B). These data reinforce the therapeutic potential of STC-1010. "This collaboration has enabled us to assess the highly representative and scalable 3D model into our SGC platform. It's a major step forward in our ability to assess potency and accelerate the development of STC-1010 and future candidates." Benoit Pinteur, CSO of Brenus Pharma. "We are proud to support Brenus with our cryopreserved 3D tumor models. This work illustrates how advanced in vitro systems can bring immunotherapies closer to clinical reality." Jan Lichtenberg, CEO of InSphero. About Brenus Pharma Brenus Pharma unlocks the potential of immuno-oncology by generating first-in-class immunotherapies that initiate a multi-specific in vivo immune response against tumors. Their proprietary "off-the-shelf" Stimulated-tumor-Ghost-Cells (SGC) platform mimics patients' tumor cells and makes them visible to the immune system to anticipate, target, and destroy these cells as they appear. Brenus aims to shift the oncology paradigm by making patients active participants in their treatment. About InSphero InSphero sets the standard for in vitro drug discovery and safety testing with innovative 3D cell-based technology and comprehensive preclinical research solutions. Its reliable, scalable and reproducible suite of 3D InSight™ Platforms for Liver Safety, Liver Disease, Islet Biology, and Oncology & Immunology are used by the top pharmaceutical companies worldwide. Learn more at View source version on Contacts contact@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
30 minutes ago
- Yahoo
European Patent Office (EPO): Neeka and Leila Mashouf win the Nature Guardians prize at the Young Inventors Prize 2025 for turning CO₂ into essential materials
28-year-old American scientists recognised for converting industrial CO₂ emissions into biodegradable cellulose Their innovation offers a scalable, low-carbon alternative to textile production The European Patent Office is awarding them EUR 20 000 for advancing sustainable material manufacturing MUNICH and REYKJAVÍK, Iceland, June 19, 2025 /PRNewswire/ -- During a ceremony held today in Iceland, the European Patent Office (EPO) awarded the twin American sisters Neeka and Leila Mashouf (28) the Nature Guardians prize for their invention, developed through their company Rubi Laboratories. Their breakthrough innovation mimics the way trees absorb carbon dioxide using enzymes to convert industrial CO₂ emissions into biodegradable cellulose that can be spun into sustainable textiles and other products. The Nature Guardians prize recognises initiatives dedicated to protecting ecosystems and biodiversity, addressing climate change, ocean health and wildlife conservation. Their work helps prevent environmental damage and restore natural balance. As this year's recipients of the Nature Guardians Prize, the Mashouf sisters received in total EUR 20 000 (EUR 5 000 awarded to each Tomorrow Shaper and an additional EUR 15 000 in recognition of this special prize). "Additional recognition from the European Patent Office propels Rubi's mission forward, as we pioneer the next era of energy-efficient manufacturing by transforming carbon into essential materials," said Neeka Mashouf, co-founder and CEO at Rubi. "A better world, where manufacturing exists in harmony with the planet, continues to serve as our North Star as we reach new milestones and make strides in commercializing our technology." The American inventors were selected by an independent jury as one of the ten winners of the Young Inventors Prize 2025, chosen from over 450 candidates worldwide. This prize celebrates innovators aged 30 and under, known as Tomorrow Shapers. From this group, three were awarded special prizes: World Builders, awarded to the French-American Marie Perrin, for promoting sustainable access to essential resources like water, energy and sustainable infrastructure; Community Healers, awarded to the Ugandan team of Sandra Namboozo and Samuel Muyita for developing solutions for food security, education, healthcare and fair working conditions; Nature Guardians, awarded to the American team. Reducing emissions through textile innovation The global textile industry is one of the most environmentally damaging supply chains, contributing up to 8% of global CO₂ emissions, according to the United Nations Environment Programme (UNEP). In response to the sector's high environmental cost, the Mashoufs developed a novel carbon conversion process that avoids the energy demands and sugar-based inputs typical of many existing technologies. Operating outside living cells in a controlled reactor, their system uses enzymes to turn captured CO₂ into cellulose pulp – the basis for biodegradable fibres. The sisters claim this method consumes ten times less energy than thermochemical alternatives and reintegrates carbon into the natural cycle. "It took countless trials, errors, and optimisations to make it all work, from producing enzymes that had never been made before to testing them in conditions no one had ever explored," said Neeka. Shaped by science, inspired by nature Neeka and Leila Mashouf were driven by a desire to tackle the environmental impact of the fashion industry. In 2021, they founded Rubi Laboratories to turn industrial CO₂ emissions into textiles using a nature-inspired enzymatic process. The company is now focused on scaling the technology and expanding its applications, with CO₂-derived cellulose already being piloted by Walmart, Patagonia and H&M. "Our focus is now on engineering and execution. It's exciting to be at the point where we can concentrate on scaling the system and bringing everything to the next level," said Neeka. Their team now includes 17 scientists and engineers specialising in enzymology, chemical engineering and carbon capture. "These skills hadn't really been combined before. It's an ongoing challenge to find the right people, which is why we always search globally—because this work requires something truly unique," she added. The Young Inventors Prize celebrates worldwide innovators 30 and under using technology to address global challenges posed by the United Nations Sustainable Development Goals (SDGs). By turning waste carbon into a valuable resource, the Mashouf sisters are directly contributing to UN SDG 9 (Industry, Innovation & Infrastructure), SDG 11 (Sustainable Cities & Communities), SDG 12 (Responsible Consumption & Production), and SDG 13 (Climate Action). The winners of the 2025 edition were announced today during a ceremony livestreamed from Iceland. Find more information about the invention's impact, the technology and the inventor's story here. About the Young Inventors Prize Aimed at individuals 30 and under, the Young Inventors Prize showcases the transformative power of youth-driven solutions and recognises the remarkable young people paving the way to a more sustainable future. Established in 2022, trophies were first handed out during the European Inventor Award ceremony. As of 2025, the Prize has moved up a gear with its own dedicated event, held separately from the Award. Among the 10 Tomorrow Shapers selected for each edition, three receive special prizes: World Builders, Community Healers, and Nature Guardians. In addition, a People's Choice winner is selected through an online public vote. Each Tomorrow Shaper receives EUR 5 000, while the three special prize winners are awarded an additional EUR 15 000. The People's Choice winner also receives an extra EUR 5 000. Read more on the Young Inventors Prize eligibility and selection criteria. About the EPO With 6,300 staff members, the European Patent Office (EPO) is one of the largest public service institutions in Europe. Headquartered in Munich with offices in Berlin, Brussels, The Hague and Vienna, the EPO was founded with the aim of strengthening co-operation on patents in Europe. Through the EPO's centralised patent granting procedure, inventors are able to obtain high-quality patent protection in up to 46 countries, covering a market of some 700 million people. The EPO is also the world's leading authority in patent information and patent searching. *Important noteB-roll materials of the inventors/invention herePicture materials of the inventors/invention here Additional videos and photos from the ceremony will be available shortlyFull ceremony video available upon request View original content: SOURCE European Patent Office (EPO) Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data